185 related articles for article (PubMed ID: 37351157)
1. Lactoferrin attenuates cardiac fibrosis and cardiac remodeling after myocardial infarction via inhibiting mTORC1/S6K signaling pathway.
Ye T; Yan Z; Chen C; Wang D; Wang A; Li T; Yang B; Ding X; Shen C
Theranostics; 2023; 13(10):3419-3433. PubMed ID: 37351157
[No Abstract] [Full Text] [Related]
2. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
3. miRNA-Mediated Suppression of a Cardioprotective Cardiokine as a Novel Mechanism Exacerbating Post-MI Remodeling by Sleep Breathing Disorders.
Du Y; Wang X; Li L; Hao W; Zhang H; Li Y; Qin Y; Nie S; Christopher TA; Lopez BL; Lau WB; Wang Y; Ma XL; Wei Y
Circ Res; 2020 Jan; 126(2):212-228. PubMed ID: 31694459
[TBL] [Abstract][Full Text] [Related]
4. TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways.
Cheng X; Wang L; Wen X; Gao L; Li G; Chang G; Qin S; Zhang D
EBioMedicine; 2021 May; 67():103370. PubMed ID: 33971401
[TBL] [Abstract][Full Text] [Related]
5. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.
Okada H; Takemura G; Kosai K; Li Y; Takahashi T; Esaki M; Yuge K; Miyata S; Maruyama R; Mikami A; Minatoguchi S; Fujiwara T; Fujiwara H
Circulation; 2005 May; 111(19):2430-7. PubMed ID: 15867170
[TBL] [Abstract][Full Text] [Related]
6. Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice.
Li J; Ge F; Wuken S; Jiao S; Chen P; Huang M; Gao X; Liu J; Tu P; Chai X; Huang L
Phytomedicine; 2022 Jun; 100():154078. PubMed ID: 35405613
[TBL] [Abstract][Full Text] [Related]
7. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
8. 2,5-Dimethylcelecoxib attenuates cardiac fibrosis caused by cryoinjury-induced myocardial infarction by suppressing the fibroblast-to-myofibroblast transformation via inhibition of the TGF-β signaling pathway.
Ikushima E; Ishikane S; Kishigami T; Matsunaga H; Igawa K; Tomooka K; Nishimura Y; Takahashi-Yanaga F
Biochem Pharmacol; 2022 Mar; 197():114950. PubMed ID: 35143754
[TBL] [Abstract][Full Text] [Related]
9. PFKFB3 Inhibitor 3PO Reduces Cardiac Remodeling after Myocardial Infarction by Regulating the TGF-β1/SMAD2/3 Pathway.
Yang Q; Zong X; Zhuang L; Pan R; Tudi X; Fan Q; Tao R
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509108
[TBL] [Abstract][Full Text] [Related]
10. The application of proteomics and metabolomics to reveal the molecular mechanism of Nutmeg-5 in ameliorating cardiac fibrosis following myocardial infarction.
Yan T; Zhu X; Zhang X; Jia X; Liu J; Wang X; Xiao Y; Xiao Z; Liu T; Dong Y
Phytomedicine; 2022 Oct; 105():154382. PubMed ID: 35963196
[TBL] [Abstract][Full Text] [Related]
11. Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways.
Chen G; Xu H; Xu T; Ding W; Zhang G; Hua Y; Wu Y; Han X; Xie L; Liu B; Zhou Y
Phytomedicine; 2022 Sep; 104():154277. PubMed ID: 35752078
[TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptor agonists alleviate fibroblast activation and post-infarction cardiac remodeling via inhibition of TGF-β1/Smad pathway.
Lin XY; Chu Y; Zhang GS; Zhang HL; Kang K; Wu MX; Zhu J; Xu CS; Lin JX; Huang CK; Chai DJ
Life Sci; 2023 Sep; 329():121936. PubMed ID: 37453576
[TBL] [Abstract][Full Text] [Related]
13. LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction.
Chen X; Zhang F; Hu G; Li X; Wang L; Li C; Huo C; Xu R; Hou L; Wang N; Wang X
Theranostics; 2022; 12(13):5824-5835. PubMed ID: 35966575
[No Abstract] [Full Text] [Related]
14. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
[TBL] [Abstract][Full Text] [Related]
15. α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways.
Alrasheed NM; Alammari RB; Alshammari TK; Alamin MA; Alharbi AO; Alonazi AS; Bin Dayel AF; Alrasheed NM
BMC Cardiovasc Disord; 2023 Mar; 23(1):153. PubMed ID: 36964489
[TBL] [Abstract][Full Text] [Related]
16. EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling.
Su SA; Yang D; Wu Y; Xie Y; Zhu W; Cai Z; Shen J; Fu Z; Wang Y; Jia L; Wang Y; Wang JA; Xiang M
Circ Res; 2017 Sep; 121(6):617-627. PubMed ID: 28743805
[TBL] [Abstract][Full Text] [Related]
17. Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction.
Masurkar N; Bouvet M; Logeart D; Jouve C; Dramé F; Claude O; Roux M; Delacroix C; Bergerot D; Mercadier JJ; Sirol M; Gellen B; Livrozet M; Fayol A; Robidel E; Trégouët DA; Marazzi G; Sassoon D; Valente M; Hulot JS
Circulation; 2023 Feb; 147(6):498-511. PubMed ID: 36484260
[TBL] [Abstract][Full Text] [Related]
18. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction.
Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222
[TBL] [Abstract][Full Text] [Related]
19. Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction.
Wang B; Tan Y; Zhou W; Yang J; Jiang Y; Liu X; Zhan Z
Matrix Biol; 2022 Sep; 112():171-189. PubMed ID: 36031013
[TBL] [Abstract][Full Text] [Related]
20. Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
Castillero E; Akashi H; Najjar M; Ji R; Brandstetter LM; Wang C; Liao X; Zhang X; Sperry A; Gailes M; Guaman K; Recht A; Schlosberg I; Sweeney HL; Ali ZA; Homma S; Colombo PC; Ferrari G; Schulze PC; George I
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H378-H390. PubMed ID: 31886717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
